Examkin

Soru

Zorluk: OrtaPharmacologic Interventions

A 28-year-old woman is brought to the emergency department by paramedics due to continuous generalized shaking of her arms and legs. Her roommate states she found her seizing 20 minutes ago. The patient has a history of epilepsy but has not taken her medications recently due to insurance issues. On arrival, she is unresponsive to verbal commands and has continuous, rhythmic, bilateral extremity jerking. Her blood pressure is 142/88 mm Hg, heart rate is 118/min, respiratory rate is 22/min, and oxygen saturation is 96% on a non-rebreather mask. Fingerstick blood glucose is 98 mg/dL. Two large-bore intravenous lines are established.

Arrange the following pharmacologic interventions in the most appropriate chronological sequence for managing this patient's condition, assuming she continues to seize despite each successive therapy.

  1. 1Intravenous lorazepam
  2. 2Intravenous levetiracetam
  3. 3Intravenous propofol infusion
  4. 4Intravenous pentobarbital

Cevap

The correct sequence for escalating pharmacologic therapy in status epilepticus is: 1) Intravenous lorazepam, 2) Intravenous levetiracetam, 3) Intravenous propofol infusion, 4) Intravenous pentobarbital.
The standard algorithm for status epilepticus management follows a rigid timeline based on the escalating risk of permanent neuronal injury. Phase 1 (5-20 minutes): Initial therapy focuses on rapid seizure cessation with an IV benzodiazepine (lorazepam, diazepam, or IM midazolam). Phase 2 (20-40 minutes): Urgent control therapy is initiated if seizures continue, using a non-benzodiazepine antiepileptic (levetiracetam, fosphenytoin, or valproic acid). Phase 3 (40-60 minutes): If seizures remain refractory, continuous IV anesthetic infusions (propofol or midazolam) are required. Phase 4 (>24 hours of refractory status): Super-refractory status epilepticus warrants deep barbiturate coma (pentobarbital) or alternative advanced neurocritical therapies.

Adım Adım Çözüm

1
Identify the clinical presentation and duration of the event.
The patient is experiencing generalized tonic-clonic status epilepticus, defined by >5 minutes of continuous seizure activity without returning to baseline.
Establishing the diagnosis of status epilepticus dictates immediate initiation of a protocolized treatment algorithm to prevent permanent neurologic damage.
2
Determine the first-line (initial stabilization) pharmacologic intervention.
Intravenous lorazepam is selected as the initial therapy.
Benzodiazepines are the preferred emergent therapy for rapidly terminating seizures due to their fast onset and enhancement of GABAergic inhibition.
3
Determine the second-line (urgent control) intervention for persistent seizures.
Intravenous levetiracetam is selected as the next step.
A long-acting non-benzodiazepine antiepileptic must be loaded if seizures persist beyond initial benzodiazepine administration to provide durable seizure control.
4
Determine the third-line (refractory) and fourth-line (super-refractory) interventions.
Intravenous propofol infusion is selected for refractory cases, followed by pentobarbital for super-refractory cases.
When standard bolus therapies fail, patients require airway protection and continuous anesthetic infusions (propofol) to achieve burst suppression on EEG. If this fails, barbiturate coma (pentobarbital) is used as a final central nervous system depressant.

Anahtar Kavram

The protocolized, step-wise management of status epilepticus escalates from rapid-acting benzodiazepines to longer-acting antiepileptics, followed by continuous anesthetic infusions, and finally barbiturate coma for super-refractory cases.
Tahmini Süre:1m 30s
Bu soruyu puanla

Konular

Pharmacologic Interventions

Bu konudan daha fazla soru